Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Select Medical Holdings (SEM) Depreciation & Amortization (IS) (2018 - 2024)

Select Medical Holdings (SEM) has disclosed Depreciation & Amortization (IS) for 7 consecutive years, with $50.1 million as the latest value for Q3 2024.

  • On a quarterly basis, Depreciation & Amortization (IS) fell 4.3% to $50.1 million in Q3 2024 year-over-year; TTM through Sep 2024 was $212.1 million, a 2.48% increase, with the full-year FY2023 number at $208.7 million, up 1.42% from a year prior.
  • Depreciation & Amortization (IS) was $50.1 million for Q3 2024 at Select Medical Holdings, down from $53.9 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $54.1 million in Q1 2024 to a low of $49.6 million in Q1 2021.
  • A 5-year average of $51.6 million and a median of $51.5 million in 2020 define the central range for Depreciation & Amortization (IS).
  • Peak YoY movement for Depreciation & Amortization (IS): dropped 5.35% in 2020, then increased 8.01% in 2024.
  • Select Medical Holdings' Depreciation & Amortization (IS) stood at $51.5 million in 2020, then rose by 0.81% to $51.9 million in 2021, then rose by 0.58% to $52.2 million in 2022, then increased by 3.33% to $54.0 million in 2023, then decreased by 7.12% to $50.1 million in 2024.
  • Per Business Quant, the three most recent readings for SEM's Depreciation & Amortization (IS) are $50.1 million (Q3 2024), $53.9 million (Q2 2024), and $54.1 million (Q1 2024).